Orofacial complications from immune checkpoint inhibitors: A retrospective analysis from two academic medical centers.
Kamal Al-EryaniJoel B EpsteinAnette Vistoso MonrealAlessandro VillaPublished in: Head & neck (2024)
Orofacial irAEs are relatively common in patients receiving ICIs, necessitating careful monitoring and management of these complications during and after the treatment.